AXXE is in Our Spotlight for Tomorrow Axxess Pharma Inc. 2681 Eglinton Ave West Toronto, Ontario Canada M6M-1T8 Phone: (416) 410-6006 axxesspharmainc.com PROFILE: Axxess Pharma: a focused healthcare company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide. We believe action defines leadership. Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy. Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE. VALUE PROPOSITION: Axxess Pharma Inc. Overview Axxess Pharma Inc. poised for immediate revenue:
- Goals - to reach 36 million year 4
- Product mass retail across North America
- Worldwide online sales distribution
World-wide exclusive license with TapouT® brand
- World leading athletic lifestyle brand - 350MM/yr
Management: Proven track record, highly experienced
Product Overview Axxess has a wide range of specialized healthcare products. Products will be launched based on priority and market demand. Specialized products include:
- Specialized vitamins
- All natural pain relief
- Diabetes-specific supplements
- Pain relief supplements
- Hot/cold therapy
2013 - 2015 Forecast - All Products (000’s)
Growth Plan Products will distributed in mass retail across the following regions:
- Canada - Currently in market
- USA - Fall of 2014
- Mexico - Fall of 2015
Target mass retailers to include: Walmart, Shoppers Drug Mart, CVS, Rexall, Walgreens, Pharmacia del la oro. Online Sales to include: Google.com, TapouT.com, UFC.com, Amazon.com
Investment Opportunity
- Private placement offering: 1MM
- Current share price: 0.851
- Discount: 65%
- Current private placement offering: 0.30/share plus bonus warrant
- Discount due to one-year stock restriction
|
|
Pink Sheets: AXXE
Market Value: 33,200,884 a/o Jul 11, 2013 Shares Outstanding: 39,059,863 a/o Mar 31, 2013 Short Interest: 1 (0%) Jun 28, 2013 Transfer Agent: Corporate Stock Transfer, Inc. RECENT NEWS: Axxess Pharma, Inc. Announces Key Addition to Management with Appointment of Senior Vice President of Sales & Marketing Axxess Pharma Inc. Receives Upgraded Listing on OTCMarkets.com KEY EXECUTIVES: Daniel Bagi, M.D. President Mr. Neil Mellor Senior Vice President Sales & Marketing Stephen Taylor Investor/Business Relations CEO/Pres. of Taylor Capitol, Inc.
|